ATNM vs ROP · rev $35.0M vs P/E 41, rev $4.20B
Actinium Pharmaceuticals Inc (ATNM) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
ATNM currently screens at market cap $33.9M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the ATNM and ROP stock pages for the full models.
Not investment advice.